Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GARTNER INC Director's Dealing 2021

Nov 15, 2021

30297_dirs_2021-11-15_fc34104f-f60e-4952-b60f-afa5951bce57.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GARTNER INC (IT)
CIK: 0000749251
Period of Report: 2021-11-10

Reporting Person: Kranich Robin B (EVP & CHRO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-10 Common Stock M 8768 $99.07 Acquired 15705 Direct
2021-11-10 Common Stock D 2637 $329.53 Disposed 13068 Direct
2021-11-10 Common Stock F 5065 $329.53 Disposed 8003 Direct
2021-11-10 Common Stock M 7905 $143.01 Acquired 15908 Direct
2021-11-10 Common Stock D 3431 $329.53 Disposed 12477 Direct
2021-11-10 Common Stock F 2568 $329.53 Disposed 9909 Direct
2021-11-10 Common Stock M 3871 $154.31 Acquired 13780 Direct
2021-11-10 Common Stock D 1813 $329.53 Disposed 11967 Direct
2021-11-10 Common Stock F 1181 $329.53 Disposed 10786 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-11-10 Stock Appreciation Rights $99.07 M 8768 Disposed 2024-02-06 Common Stock (8768) Direct
2021-11-10 Stock Appreciation Rights $143.01 M 7905 Disposed 2026-02-06 Common Stock (7905) Direct
2021-11-10 Stock Appreciation Rights $154.31 M 3871 Disposed 2027-02-05 Common Stock (3871) Direct

Footnotes

F1: Represents shares acquired upon exercise of SARs.

F2: Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs.

F3: Represents shares withheld from the settlement of the SARs for the payment of applicable income and payroll tax withholding due upon exercise.

F4: These SARs were part of an award that became exercisable in four substantially equal, annual installments commencing on February 6, 2018 and were fully exercisable.

F5: These SARs were part of an award that becomes exercisable in four substantially equal, annual installments commencing on February 6, 2020.

F6: These SARs were part of an award that becomes exercisable in four substantially equal, annual installments commencing on February 5, 2021.